A medical worker performs a coronavirus test at a test centre at Vnukovo airport outside Moscow, Russia.
The Indian Council of Medical Research (ICMR) Director-General Balram Bhargava during a discussion with lawmakers on how long people will have to live with the pandemic and wait for the coronavirus vaccine, said that normally the final trial takes about 6 to 9 months but if the governments decide, emergency authorisation of a vaccine could be considered. Bhargava informed a parliamentary panel that phase-2 clinical trial of two indigenously developed COVID-19 vaccine candidates have almost been completed and emergency authorisation of a vaccine could be considered if the Centre decides so.
Govt may consider emergency authorisation of coronavirus vaccine: What we know so far
- ICMR director general informed members of the parliamentary standing committee on home affairs that the vaccine candidates developed by Bharat Biotech, Cadila and the Serum Institute of India are at different stages of trial.
- The coronavirus vaccine candidates coordinated by Bharat Biotech and Cadila are nearing completion of phase-2 trails.
- The one being handled by the Serum Institute of India and developed by Oxford University-AstraZeneca will enter phase-2 (b) trials this weekend for which 1,700 patients have been identified at 17 centres across the country.
- Answering how long people will have to wait for the coronavirus vaccine, Bhargava replied that normally the final trial takes about six to nine months but if the governments decides, an emergency authorisation could be considered.
- Responding to queries by the panel about the saliva test cleared by FDA in the US for rapid detection of SARS-CoV-2, Bhargava informed that taking samples from gargled water is already under consideration and further details will be available soon.
- Members of the parliamentary committee cutting across party lines complemented the ICMR in particular and the medical fraternity in general for their committed role in fighting the pandemic.
- They appreciated the ICMR for its pioneering role in coordinating the scientific and medical aspects of the battle against COVID-19 and appreciated AIIMS, Delhi, for its effective contribution as a lead mentor for hospitals across the country on various aspects of the pandemic management.
- The committee members expressed concern over stigmatisation of infected people both by kin and neighbours and noted that those afflicted by COVID-19 and have recovered are not harmful, instead beneficial to the society.
- About the mental stress among the people due to the pandemic, ICMR agreed to the panel members' suggestion of reviewing the existing limited set of guidelines relating to management of psychological stress.
- The apex medical research body also told the committee that it may soon come out with comprehensive revised guidelines so as to help all the concerned to cope with the stress caused by the outbreak of the viral disease.
- Among various issues raised, the panel members drew the ICMR's attention to the situation being faced by school children in particular, as with online learning they are required to spend long hours in front of computers and other gadgets which is adversely impacting their eyesight and causing psychological stress.
The meeting, chaired by senior Congress leader and Rajya Sabha MP Anand Sharma, lasted for over four hours and discussed various aspects of management of the COVID-19 pandemic and also its impact on the micro, small and medium enterprises (MSME) sector.
Secretary, Ministry of MSMEs, Arvind Kumar Sharma also appeared before the panel and briefed it about the impact of pandemic on the sector.
Chairman of the parliamentary standing committee Anand Sharma stressed that the sector which contributes 50 per cent of the total exports, 30 per cent of GDP besides employing over 11 crore people was among the worst hit by the pandemic.
The Secretary in the Ministry of MSMEs informed the panel that only 9 per cent of the total 6.33 crore MSME units have been shut due to the pandemic and there has been an improvement in capacity utilisation over the last few months.
Anand Sharma said the committee would like to present a detailed report on the handling of pandemic to both the Houses of Parliament in the Monsoon Session based on the experiences of various stakeholders and lessons learned which would serve as a useful guide for the future, sources said.
ALSO READ | India coronavirus recoveries near 21 lakh as recovery rate touches 74 per cent
ALSO READ | Coronavirus vaccine will be ready by December, two shots to cost less than Rs 10,000: SinoPharm
